We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCSL icon
12951
Oaktree Specialty Lending
OCSL
$1.14B
$10.7K ﹤0.01%
533
-52
-9% -$1.04K
ORN icon
12952
PUT
Orion Group Holdings
ORN
$402M
$10.7K ﹤0.01%
2,000
-400
-17% -$1.58K
RVP icon
12953
CALL
Retractable Technologies
RVP
$20.7M
$10.7K ﹤0.01%
9,000
-500
-5% -$588
HRTX icon
12954
Heron Therapeutics
HRTX
$63.9M
$10.7K ﹤0.01%
10,390
-425,601
-98% -$606K
AAIC
12955
CALL
DELISTED
Arlington Asset Investment Corp.
AAIC
$10.7K ﹤0.01%
2,500
-900
-26% -$4.08K
BGMS
12956
Bio Green Med Solution Inc
BGMS
$5.05M
$10.7K ﹤0.01%
9
+6
+200% +$10.5K
YI
12957
CALL
111 Inc
YI
$32.3M
$10.7K ﹤0.01%
410
+400
+4,000% +$11.2K
EBF icon
12958
PUT
Ennis
EBF
$559M
$10.6K ﹤0.01%
500
+100
+25% +$2.12K
NMTC icon
12959
CALL
NeuroOne Medical Technologies
NMTC
$17.7M
$10.6K ﹤0.01%
+1,983
New +$13.3K
PSO icon
12960
PUT
Pearson
PSO
$9.72B
$10.5K ﹤0.01%
+1,000
New +$10.7K
PYR
12961
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$10.5K ﹤0.01%
+24,257
New +$15.3K
JHX icon
12962
CALL
James Hardie Industries
JHX
$18B
$10.5K ﹤0.01%
400
+300
+300% +$8.48K
CFFN icon
12963
PUT
Capitol Federal Financial
CFFN
$1.08B
$10.5K ﹤0.01%
2,200
-600
-21% -$3.55K
DXPE icon
12964
PUT
DXP Enterprises
DXPE
$3.12B
$10.5K ﹤0.01%
300
-200
-40% -$7.22K
SEEL
12965
PUT
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$10.5K ﹤0.01%
15
+8
+114% +$34.3K
INO icon
12966
PUT
Inovio Pharmaceuticals
INO
$113M
$10.5K ﹤0.01%
2,242
+609
+37% +$3.36K
AIMDW icon
12967
Ainos Warrants
AIMDW
$10.5K ﹤0.01%
32,022
+1,180
+4% +$220
BRFS
12968
CALL
DELISTED
BRF SA
BRFS
$10.5K ﹤0.01%
5,100
-2,600
-34% -$5.08K
INN
12969
CALL
Summit Hotel Properties
INN
$651M
$10.4K ﹤0.01%
1,800
-2,500
-58% -$14.9K
LXFR icon
12970
CALL
Luxfer Holdings
LXFR
$457M
$10.4K ﹤0.01%
800
+200
+33% +$2.52K
DOLE icon
12971
PUT
Dole
DOLE
$1.26B
$10.4K ﹤0.01%
900
-16,700
-95% -$209K
ENSV
12972
DELISTED
Enservco Corp.
ENSV
$10.4K ﹤0.01%
+27,296
New +$10.1K
FBIO icon
12973
CALL
Fortress Biotech
FBIO
$97.7M
$10.4K ﹤0.01%
2,387
+2,007
+528% +$13.8K
WTTR icon
12974
PUT
Select Water Solutions
WTTR
$2.69B
$10.3K ﹤0.01%
1,300
-41,100
-97% -$338K
STEX
12975
CALL
Streamex Corp
STEX
$108M
$10.3K ﹤0.01%
2,110
-4,690
-69% -$35.2K
517 518
519
520 521

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.